Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;21(4):237-42.
doi: 10.1097/FPC.0b013e32833c6107.

PharmGKB summary: fluoropyrimidine pathways

Caroline F Thorn  1 , Sharon Marsh, Michelle Whirl Carrillo, Howard L McLeod, Teri E Klein, Russ B Altman
Affiliations

PharmGKB summary: fluoropyrimidine pathways

Caroline F Thorn et al. Pharmacogenet Genomics. 2011 Apr.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Graphic representation of the candidate genes involved in fluoropyrimidine pharmacokinetics. A fully interactive version of this pathway is available online at PharmGKB at http://www.pharmgkb.org/do/serve?objId=PA150653776&objCls=Pathway. 5′-dFCR, 5′-deoxy-5-fluorocytidine; 5′-dFUR, 5′-deoxy-5-fluorouridine; 5-FU, 5-fluorouracil; ABCC, ATP-binding cassette, sub-family C; CDA, cytidine deaminase; CES, carboxylesterase; DHFU, dihydrofluorouracil; DPYD, dihydropyrimidine dehydrogenase’; DPYS, dihydropyrimidinease; FBAL, fluoro-β-alanine; FdUDP, fluorodeoxyuridine diphosphate; FdUMP, fluorodeoxyuridine monophosphate; FdUTP, fluoro-deoxyuridine triphosphate; FUDP, fluorouridine diphosphate; FUDR, fluorodeoxyuridine; FUMP, fluorouridine monophosphate; FUPA, fluoro-β-ureidopropionate; FUR, fluroridine; FUTP, fluorouridine triphosphate; PD, pharmacodynamic; PPAT, phosphoribosyl pyrophosphate amidotransferase; RRM, ribonucleotide reductase M; TK1, thymidine kinase 1; Tp53, tumor protein p53; TYMP, thymidylate phosphorylase; TYMS, thymidylate synthase; UCK, uridine-cytidine kinase; UMPS, uridine monophosphate synthase; UPB1, β-ureidopropionase 1; UPP, uridine phosphorylase.
Fig. 2
Fig. 2
Graphic representation of the candidate genes involved in fluoropyrimidine pharmacodynamics. A fully interactive version of this pathway is available online at PharmGKB at http://www.pharmgkb.org/search/pathway/5fu/5fu-pd.jsp. DHF, dihydrofolate; DHFR, dihydrofolate reductase; dTMP, deoxythymidine monophosphate; dUMP, deoxyuridine monophosphate; ERCC, excision repair cross complementing; FdUMP, fluorodeoxyuridine monophosphate; FdUTP, fluoro-deoxyuridine triphosphate; FPGS, folylpolyglutamate synthase; FUTP, fluorouridine triphosphate; GGH, Gammaglutamyl hydrolase; MTHFR, methylenetetrahydrofolate reductase; PK, pharmacokinetics; SMUG1, Single-strand selective monofunctional uracil DNA glycosylase 1; TDG, thymidine DNA glycosylase; THF, 5,10-methylene tetrahydrofolate; TYMS, thymidylate synthase.
See this image and copyright information in PMC

References

    1. Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989;16:215–237. - PubMed
    1. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330–338. - PubMed
    1. Hwang JJ, Marshall JL. Capecitabine: fulfilling the promise of oral chemotherapy. Expert Opin Pharmacother. 2002;3:733–743. - PubMed
    1. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer. 1998;34:1274–1281. - PubMed
    1. Yen-Revollo JL, Goldberg RM, McLeod HL. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines? Clin Cancer Res. 2008;14:8–13. - PubMed

Publication types